Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.

Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, Roth E, Jungvig L, Mojica WA, Gagné J, Rhodes S, McKinnon E.

Evid Rep Technol Assess (Summ). 2003 Mar;(76):1-4. No abstract available.

2.

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.

JAMA. 2003 Mar 26;289(12):1537-45. Epub 2003 Mar 10.

PMID:
12672771
3.

Ephedra: once a boon, now a bane.

Scheindlin S.

Mol Interv. 2003 Oct;3(7):358-60. No abstract available.

PMID:
14993455
4.
5.

[Ephedrine and ephedra in weight loss products and other preparations].

van der Hooft CS, Stricker BH.

Ned Tijdschr Geneeskd. 2002 Jul 13;146(28):1335-6. Dutch.

PMID:
12148223
6.

Medicine. Ephedra--scientific evidence versus money/politics.

Wolfe SM.

Science. 2003 Apr 18;300(5618):437. No abstract available. Erratum in: Science. 2003 May 21;300(5621):905.

PMID:
12702860
7.

Ergogenic aids: an update on ephedra.

Keisler BD, Hosey RG.

Curr Sports Med Rep. 2005 Aug;4(4):231-5. Review.

PMID:
16004835
8.

The need for regulation of dietary supplements--lessons from ephedra.

Fontanarosa PB, Rennie D, DeAngelis CD.

JAMA. 2003 Mar 26;289(12):1568-70. Epub 2003 Mar 10. No abstract available.

PMID:
12672775
9.

Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.

Miller SC.

Mil Med. 2004 Feb;169(2):87-93. Review.

PMID:
15040625
10.

Banning ephedra: good call, poor vision.

Gordon JS.

Altern Ther Health Med. 2004 Nov-Dec;10(6):18-9. No abstract available.

PMID:
15624346
11.

Legal ephedra?

[No authors listed]

Consum Rep. 2010 Mar;75(3):11. No abstract available.

PMID:
20358659
13.

Ephedra ban: no shortage of reasons.

Rados C.

FDA Consum. 2004 Mar-Apr;38(2):6-7.

14.

Ephedrine alkaloids banned from dietary supplements.

Thompson CA.

Am J Health Syst Pharm. 2004 Apr 15;61(8):750-2, 756. No abstract available.

PMID:
15127956
15.

FDA v. ephedra: is it time to lift the ban?

Pyle KR.

Food Drug Law J. 2006;61(4):701-51. No abstract available.

PMID:
17180770
16.
17.

JAMA patient page. Ephedra and ephedrine.

Torpy JM, Lynm C, Glass RM.

JAMA. 2003 Mar 26;289(12):1590. No abstract available.

PMID:
12672776
18.

Cardiovascular effects of ephedra alkaloids: a comprehensive review.

Andraws R, Chawla P, Brown DL.

Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. Review.

PMID:
15991150
19.

Addressing the potential risks associated with ephedra use: a review of recent efforts.

Schulman S.

Public Health Rep. 2003 Nov-Dec;118(6):487-92. Review.

20.

Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.

Gurley BJ, Steelman SC, Thomas SL.

Clin Ther. 2015 Feb 1;37(2):275-301. doi: 10.1016/j.clinthera.2014.08.012. Epub 2014 Sep 26. Review.

PMID:
25262198

Supplemental Content

Support Center